Skip to main content

CPSF4L Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-82756

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-82756-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of Human CPSF4L. Peptide sequence: EKDVEMQKGTGLLPFQGMDKSASAVCNFFTKGLCEKGKLCPFRHDRGEKM The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for CPSF4L Antibody

Western Blot: CPSF4L Antibody [NBP2-82756]

Western Blot: CPSF4L Antibody [NBP2-82756]

Western Blot: CPSF4L Antibody [NBP2-82756] - Host: Rabbit. Target Name: CPSF4L. Sample Type: 293T Whole Cell lysates. Antibody Dilution: 1.0ug/ml

Applications for CPSF4L Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: CPSF4L

Alternate Names

cleavage and polyadenylation specific factor 4-like, putative cleavage and polyadenylation specificity factor subunit 4-like protein

Gene Symbol

CPSF4L

Additional CPSF4L Products

Product Documents for CPSF4L Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for CPSF4L Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...